文献速递传染病防控与疫情报告卫生政策与健康促进

埃及丙型肝炎病毒传播中注射用抗血吸虫治疗的历史作用

Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt.
PubMed 文献 · Int J Epidemiol · 2020-01-01

该研究构建数学模型并拟合埃及人口与健康调查及系统数据库,分析丙型肝炎病毒(HCV)传播动态。结果显示,HCV发病率在1966年达到峰值15.7例/1000人年,与注射用抗血吸虫治疗(PAT)运动时间重合,但PAT仅解释约6%的感染,提示其可能是流行病的表现而非原因。

要点

  • HCV发病率1966年达峰15.7例/1000人年,与PAT运动重合。
  • PAT相关感染仅占约6%,不足以解释整体流行。

核心结论

  • PAT运动在HCV传播中起重要作用,但仅解释6%的感染,可能是流行病的表现而非原因。
  • HCV发病率在1966年达峰后快速下降,自1990年代中期开始显著减少。

研究设计与样本

  • 构建数学模型并拟合埃及人口与健康调查数据及HCV患病率系统数据库。

主要发现

  • HCV发病率在1966年达峰15.7例/1000人年,与PAT运动时间重合。

临床怎么用

  • 提示HCV防控需关注医疗质量不足等潜在驱动因素,而非仅针对PAT运动。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Egypt is the nation most affected by hepatitis C virus (HCV) infection, following an epidemic of historic proportions. We aimed to characterize the epidemic's historical evolution and to delineate the role of parenteral antischistosomal therapy (PAT) campaigns in transmission. METHODS: A mathematical model was constructed and analysed in order to understand HCV-transmission dynamics. The model was fitted to Egypt's Demographic and Health Survey data and to a systematic database of HCV-prevalence data. RESULTS: The incidence rate peaked in 1966 at 15.7 infections per 1000 person-years-a period of time that coincides with the PAT campaigns-and rapidly declined thereafter, beginning the mid-1990s. The annual number of new infections peaked in 1993 at 581 200 (with rapid demographic growth), leading to a high-incidence-cohort effect, and declined to 67 800 by 2018. The number of individuals ever infected (1950-2018) was 16.4 million, with HCV prevalence peaking in 1979. The number of individuals ever exposed to PAT was 8.3 million; however, of these individuals, 7.3 million were alive in 1980 and only 3.5 million alive in 2018. The number of individuals ever infected due to PAT exposure was 963 900, with 850 200 individuals alive in 1980 and only 389 800 alive in 2018. The proportion of PAT-attributed prevalent infections peaked at 19.9% in 1972, declining to 5.5% by 2018. CONCLUSIONS: PAT campaigns played an important role in HCV transmission, yet explain only 6% of infections-they appear to be a manifestation, rather than a cause, of the epidemic. A possible driver of the epidemic could be the mass expansion of inadequate-quality healthcare during PAT campaigns and subsequent decades. Despite a historic toll, the epidemic has been rapidly diminishing since the mid-1990s.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Ayoub HH, Chemaitelly H, Kouyoumjian SP, et al. Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt. Int J Epidemiol. 2020. PMID: 32357208. doi:10.1093/ije/dyaa052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。